Inventiva among SBF 120 leaders: stock advances nearly 4%
The Burgundy-based biotech specializing in fibrotic and metabolic diseases is moving forward mid-morning, in a rising SBF 120. This renewed activity comes after a very difficult month and remains, for now, a simple rebound movement.
A rebound that leaves the stock far from its moving averages
The Inventiva stock gains 3.93% to €2.91, placing it among the strongest gainers in the SBF 120, which itself advances by 0.92%. In the previous session, the stock had lost further ground in a declining index. However, today's rebound does not change the overall picture: the price remains 5.83% below its 20-day moving average and 20.05% below its 50-day moving average, while the decline has reached 27.7% over one month. The support level at €2.77, already at the heart of several recent sessions, is found at approximately 5% below the current price, and the RSI at 34 reflects the accumulated selling fatigue accumulated in recent weeks.
Short positions on the rise and strengthened cash position in the first half
According to reviewed disclosures, two funds hold 1.14% of capital in net short position, a level that has increased by 1.14 percentage points in thirty days. This rapid increase signals a bearish positioning that has been established recently, without the level reached reflecting a massive bet against the stock. On the fundamentals side, Inventiva published its H1 2026 results on July 30: no revenue for the half-year, compared to €4.5 million a year earlier, but cash reserves brought to €166.1 million following the restructuring of its financing.
The group indicated at the time that its resources would allow it to operate until the end of the second quarter of 2027 without additional financing. The next concrete reference point remains the €2.77 level, whose maintenance or breach will determine the continuation of the movement.
